Feb 22 (Reuters) - Otsuka:
* HEALTH CANADA APPROVES OTSUKA AND LUNDBECK'S REXULTI (BREXPIPRAZOLE) AS ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER
Feb 22 (Reuters) - Otsuka:
* HEALTH CANADA APPROVES OTSUKA AND LUNDBECK'S REXULTI (BREXPIPRAZOLE) AS ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER